Advancements in Spinal Muscular Atrophy (SMA) Genetic Testing: Revolutionizing Diagnosis with Tianlong
Release Date 2023-08-15

As a pioneer in genetic testing and molecular diagnostics, Tianlong has played a crucial role in advancing medical breakthroughs. In this blog post, we will explore the significance of recent advancements in SMA genetic testing and their impact on patient outcomes.

The evolution of SMN1 gene detection techniques

Traditionally, PCR-based techniques have been used for spinal muscular atrophy SMN1 gene detection. While these methods have served as valuable tools, they come with certain limitations and challenges. For instance, they may lack accuracy and sensitivity, making it difficult to obtain reliable results. However, with advancements in technology and the understanding of the spinal muscular atrophy SMN1 gene, newer techniques have been developed to overcome these limitations. One such technique is the multiplex ligation-dependent probe amplification (MLPA) assay. This method allows for the detection of deletions or duplications in the SMN1 gene, providing more precise results compared to traditional PCR-based methods. MLPA offers enhanced sensitivity and specificity, making it a preferred choice in clinical settings.

Introducing the innovative PCR melting curve method

Here at Tianlong, we understand the importance of accurate and efficient genetic testing. That's why we have developed the cutting-edge PCR melting curve method, which is utilized in our spinal muscular atrophy SMN1 Gene Detection Kit-P124H. This revolutionary technique overcomes the limitations of traditional methods by offering enhanced precision and reliability.

Enhanced accuracy and efficiency in SMA diagnosis

The PCR melting curve method provides improved accuracy and sensitivity in detecting SMN1 gene copy numbers. Our Tianlong Human Survival Motor Neuron 1 (SMN1) Gene Detection Kit-P124H offers exceptional performance in accurately differentiating between 0, 1, and >2 copies of SMN1, enabling precise SMA diagnosis.

Moreover, our kit reduces complexity and streamlines workflow, allowing healthcare professionals to achieve rapid turnaround times. By simplifying the testing process, we empower medical teams to make prompt and informed decisions regarding patient care.


Thanks to Tianlong's spinal muscular atrophy SMN1 Gene Detection Kit-P124H, significant advancements in SMA genetic testing have become a reality. The precision, accuracy, and efficiency of the PCR melting curve method have revolutionized SMA diagnosis, ultimately leading to improved patient outcomes.

Accurate SMA diagnosis plays a pivotal role in patient care and management. It enables early intervention, personalized treatment plans, and access to appropriate resources and support systems. At Tianlong, we remain committed to innovation in molecular diagnostics as we continue to contribute to the advancement of medical science and the well-being of patients worldwide.